BIOEQUIVALENCE OF FIXED DOSE COMBINATION (FDC) TABLETS OF EMPAGLIFLOZIN/METFORMIN EXTENDED RELEASE COMPARED WITH THE FREE COMBINATIONS IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Lippert, C. [1 ]
Sennewald, R. [1 ]
Elsasser, U. [1 ]
Huettner, S. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-081
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [1] BIOEQUIVALENCE OF FIXED DOSE COMBINATION (FDC) TABLETS OF LINAGLIPTIN/METFORMIN EXTENDED RELEASE COMPARED WITH THE FREE COMBINATIONS IN HEALTHY VOLUNTEERS
    Lippert, C.
    Sennewald, R.
    Bell, J.
    Wiebe, S.
    Huettner, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S32 - S32
  • [2] PHARMACOKINETICS OF FIXED DOSE COMBINATION (FDC) TABLETS OF LINAGLIPTIN/METFORMIN EXTENDED RELEASE COMPARED WITH THE FREE COMBINATIONS IN HEALTHY VOLUNTEERS.
    Norman, P.
    Lippert, C.
    Hummel, N.
    Hunt, T.
    Huettner, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S46 - S46
  • [3] Pharmacokinetics of fixed-dose combinations of empagliflozin/metformin compared with individual tablets in healthy subjects
    Rojas, Christina
    Link, Jasmin
    Meinicke, Thomas
    Macha, Sreeraj
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 282 - 292
  • [4] Bioequivalence of vildagliptin/metformin fixed-dose combination tablets and a free combination of vildagliptin and metformin in healthy subjects
    He, Y-L.
    Paladini, S.
    Sabia, H.
    Campestrini, J.
    Zhan, Y.
    Leon, S.
    Ligueros-Saylan, M.
    Jarugula, V.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (05) : 259 - 267
  • [5] COMPARATIVE PHARMACOKINETICS OF EXTENDED-RELEASE VERSUS CONVENTIONAL TRAMADOL/ACETAMINOPHEN FIXED-DOSE COMBINATION TABLETS IN HEALTHY VOLUNTEERS.
    Yi, S. J.
    Kim, T. E.
    Jeon, H. W.
    Shin, H. S.
    Yoon, S. H.
    Cho, J. Y.
    Yu, K. S.
    Jang, I. J.
    Shin, S. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S87 - S88
  • [6] Bioequivalence and food effect assessment for vildagliptin/metformin fixed-dose combination tablets relative to free combinations of vildagliptin and metformin in Japanese healthy subjects
    Mita, Sachiko
    Chitnis, Shripad D.
    Kulmatycki, Kenneth
    Salunke, Atish
    Het, Yan-Ling
    Zhou, Wei
    Suzuki, Hikoe
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 305 - 314
  • [7] Bioequivalence (BE) of Saxagliptin (SAXA)/Dapagliflozin (DAPA) Fixed Dose Combination (FDC) Tablets Compared with Coadministration of the Individual Tablets
    Vakkalagadda, Blisse
    Vetter, Marion
    Rana, Jignasa
    Smith, Charles H.
    Haung, Jian
    Karkas, Jennifer
    Boulton, David W.
    Lacreta, Frank
    DIABETES, 2015, 64 : A325 - A325
  • [8] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects
    Boulton, David W.
    Smith, Charles H.
    Li, L.
    Huang, Jian
    Tang, Angela
    LaCreta, Frank P.
    CLINICAL DRUG INVESTIGATION, 2011, 31 (09) : 619 - 630
  • [9] Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects
    David W. Boulton
    Charles H. Smith
    L. Li
    Jian Huang
    Angela Tang
    Frank P. LaCreta
    Clinical Drug Investigation, 2011, 31 : 619 - 630
  • [10] Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects
    Boulton, David W.
    Chang, Ming
    Griffen, Steven C.
    Kitaura, Catia
    Lubin, Susan
    Pollack, Allyson
    LaCreta, Frank
    CLINICAL THERAPEUTICS, 2016, 38 (01) : 99 - 109
12345